Shoujiao Peng

10PUBLICATIONS
18CO-AUTHORS
Biologically active moleculesChemotherapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Free radical chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 14, 2026
Synthesis and Biological Evaluation of RBG Derivatives as Nrf2 Activators for the Treatment of Parkinson's Disease.

Wen-Qing Shi, Jia-Hua Zhuang, Qiu-Heng Zhang

|Mar 26, 2025
Salidroside Derivative SHPL-49 Exerts Anti-Neuroinflammatory Effects by Modulating Excessive Autophagy in Microglia.

Zhirui Zheng, Ruyi Wang, Yu Zhao

|Oct 26, 2024
Bufotalin Induces Oxidative Stress-Mediated Apoptosis by Blocking the ITGB4/FAK/ERK Pathway in Glioblastoma.

Junchao Tan, Guoqiang Lin, Rui Zhang

|Mar 11, 2023
6-Shogaol as a Novel Thioredoxin Reductase Inhibitor Induces Oxidative-Stress-Mediated Apoptosis in HeLa Cells.

Shoujiao Peng, Shaopeng Yu, Junmin Zhang

|Dec 22, 2022
Tumor-derived OBP2A promotes prostate cancer castration resistance.

Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li

|Mar 26, 2022
Choosing Kinase Inhibitors for Androgen Deprivation Therapy-Resistant Prostate Cancer.

Shangwei Zhong, Shoujiao Peng, Zihua Chen

Pageof 2

Frequent Collaborators

2 joint publications

Jianguo Fang

2 joint publications

Juan Yao

2 joint publications

Jun-Li Luo

1 joint publications

Liangwei Zhang